SEMPECTO
LIVE

Serial Number

79395817

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SEMPECTO Trademark

Serial Number: 79395817 • Registration: 7592830

SEMPECTO is a trademark filed by NOVARTIS AG on February 26, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 26, 2024

Registration Date

December 10, 2024

Published for Opposition

October 8, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 31, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 15, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 15, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 9, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2024 PUBO
NOTICE OF PUBLICATION
Sep 18, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2024 CNSA
ASSIGNED TO EXAMINER
Aug 29, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 29, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 29, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 29, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 29, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 29, 2024 COAR
APPLICATION FILING RECEIPT MAILED
May 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 20, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 16, 2024 REPR